U.S. Markets close in 2 hrs 53 mins

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.18+0.34 (+2.15%)
As of 1:07PM EDT. Market open.
People also watch
INFIEPZMMNTAAEGRSGYP
Full screen
Previous Close15.84
Open15.79
Bid16.11 x 1000
Ask16.13 x 200
Day's Range15.64 - 16.18
52 Week Range12.48 - 19.94
Volume370,547
Avg. Volume1,203,096
Market Cap2.42B
Beta1.47
PE Ratio (TTM)-16.58
EPS (TTM)-0.98
Earnings DateNov 1, 2017 - Nov 6, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.23
Trade prices are not sourced from all markets
  • Capital Cube12 days ago

    ETFs with exposure to Ironwood Pharmaceuticals, Inc. : September 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017
    Capital Cube14 days ago

    Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017

    Categories: Yahoo FinanceGet free summary analysis Ironwood Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. ... Read more (Read more...)

  • Business Wire19 days ago

    Ironwood Pharmaceuticals Announces Leadership Change

    Ironwood Pharmaceuticals, Inc. announced today that Tom Graney, chief financial officer and senior vice president, finance and corporate strategy will leave the company, effective September 13, 2017, to pursue another opportunity.